Author Question: Patients whose ____ has been damaged can perform well on long-term memory tasks but have trouble ... (Read 88 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
Patients whose ____ has been damaged can perform well on long-term memory tasks but have trouble keeping information in their short-term memory.
 
  a. basal ganglia
 b. perisylvian cortex
  c. cerebellum
 d. cerebral cortex

Question 2

Patients who have sustained damage to the ____ have difficulty in storing new information or retrieving old memories from their long-term store.
 
  a. basal ganglia
  b. hippocampus
  c. cerebellum
 d. amygdala



ApricotDream

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

b

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library